Here, we present the first comprehensive evidence that PLEK expression in tumor-infiltrating macrophages contributes to anti-tumor immunity in OS, potentially by reprogramming metabolic and signaling networks within the TME. The gene discussed is PLEK; the disease is neoplasm.